<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00570271</url>
  </required_header>
  <id_info>
    <org_study_id>EA4/004/07</org_study_id>
    <secondary_id>EA4/004/07</secondary_id>
    <nct_id>NCT00570271</nct_id>
  </id_info>
  <brief_title>Placebo Effects on Blood Pressure</brief_title>
  <official_title>Physiological Effects of Placebo Interventions to Increase or Decrease Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A relevant reduction of blood pressure (BP) in placebo-treated control groups is a phenomenon
      often observed in pharmacological studies of hypertension. This effect was shown to differ
      from spontaneous remission tendencies and regression to the mean effect by comparing placebo
      groups with untreated controls. However, it is not fully understood whether these effects are
      due to a global reaction of the autonomous nervous system (affecting the overall organ
      systems of the body) or a specific reaction (affecting the cardiovascular system only). We
      therefore aim to differentiate specific effects (reduction of blood pressure) from global
      effects (e.g. changes in electrodermal and gastric activity).

      In our study we aim to test the following hypotheses:

        1. Placebo administration leads to a significant changes of blood pressure compared with
           untreated controls.

        2. The direction of blood pressure change depends on the type of suggestion (either
           decrease or increase)

        3. This effect is specific for blood pressure; changes in electrodermal and gastric
           activity do not differ between groups.

        4. The placebo response can be enhanced by a prestige intervention (information about the
           suggested drug action given by doctor or in written form).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2007</start_date>
  <completion_date type="Anticipated">February 2008</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>60 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>skin conductance level</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gastric activity</measure>
    <time_frame>60 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo with BP dec (written form)</intervention_name>
    <description>Placebo administration with a blood pressure decrease suggestion. Information provided to subjects in written form.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo with BP dec (doctor)</intervention_name>
    <description>Placebo administration with a blood pressure decrease suggestion. Information provided to subjects by doctor.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo with BP inc (written)</intervention_name>
    <description>Placebo administration with a blood pressure increase suggestion. Information provided to subjects in written form.</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo with BP inc (doctor)</intervention_name>
    <description>Placebo administration with a blood pressure increase suggestion. Information provided to subjects by doctor.</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo info given (written)</intervention_name>
    <description>Subject informed about receiving placebo. Information provided to subjects in written form.</description>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo info given (doc)</intervention_name>
    <description>Subject informed about receiving placebo. Information provided to subjects by doctor.</description>
    <arm_group_label>6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

        Exclusion Criteria:

          -  Not meeting inclusion criteria

          -  Untreated hypertension (BP &gt; 140/90) or hypotension(BP &lt; 100/60)

          -  Severe systemic disorders (tumors, tbc, diabetes, asthma etc)

          -  Diseases with influence on cardiovascular or gastrointestinal system

          -  Pregnancy and lactation phase

          -  Body mass index &gt; 30

          -  Regular intake of drugs with influence on the autonomic nervous system

          -  Insufficient compliance

          -  Simultaneous participation in another trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans-Christian Deter, MD</last_name>
    <role>Study Director</role>
    <affiliation>Charité University Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frank Zimmermann-Viehoff, MD</last_name>
    <phone>+49-30-84454046</phone>
    <email>frank.zimmermann@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Psychosomatic Medicine and Psychotherapy, Charité University</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2007</study_first_submitted>
  <study_first_submitted_qc>December 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2007</study_first_posted>
  <last_update_submitted>December 7, 2007</last_update_submitted>
  <last_update_submitted_qc>December 7, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2007</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. H.-C. Deter</name_title>
    <organization>Dept of Psychosomatic Medicine and Psychotherapy, Benjamin Franklin Campus, Charité,Berlin</organization>
  </responsible_party>
  <keyword>placebo effect</keyword>
  <keyword>blood pressure</keyword>
  <keyword>autonomic nervous system</keyword>
  <keyword>prestige</keyword>
  <keyword>basic research on physiological placebo effects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

